Unlock transformative cancer insights
Oxford Nanopore sequencing offers a unique multiomic solution for cancer research and precision oncology. With real-time analysis of native DNA and RNA fragments of any length, capture previously hidden variants and modifications in a single consolidated assay.
Why choose Oxford Nanopore?
Comprehensive multiomic insights to unlock more cancer biology
Simple end-to-end workflows for streamlined bioinformatic analysis
Direct RNA nanopore sequencing for the most complete view of the cancer transcriptome
)
It’s a real joy to use adaptive sampling. It’s a very cost-effective and efficient process. We’ve used it across many projects.Tom Walsh
University of Washington
)
PromethION range
PromethION Flow Cells offer the highest output for nanopore sequencing, achieving enhanced coverage of cancer genomes and high-resolution analysis of full-length transcripts. The PromethION range of devices is ideal for comprehensive whole-genome characterisation and biomarker discovery across any number of cancer samples.
)
)
Accelerating cancer research through comprehensive genomic analysis
In this white paper, discover how Oxford Nanopore sequencing technology provides extensive analyses of structural variants, repeat regions, methylation, cell-free and circulating tumour DNA (cfDNA and ctDNA), fusion genes — in one go — to truly understand cancer biology.
